| Previous Section | Index | Home Page |
12 Oct 2004 : Column 261W—continued
Patient Statistics (Wandsworth)
Tom Cox: To ask the Secretary of State for Health how many patients there were per general practitioner within the London borough of Wandsworth at the most recent recorded date. [174494]
Mr. Hutton [pursuant to his reply, 24 May 2004, Official Report, c. 1389W]: I regret my previous response was incorrect, due to an error in the published figures. The correct figures are shown in the table.
| Wandsworth PCT | |
|---|---|
| UPEs | 174 |
| Patients of UPEs | 309,365 |
| Average list size | 1,778 |
(28) UPEs include GMS unrestricted principals, PMS contracted general practitioners and PMS salaried GPs.
Data as at 30 September 2003.
Patient data have been revised from previously published figures.
Source:
Department of Health general and personal medical services statistics.
Post-Laryngectomy Equipment
Mrs. Helen Clark: To ask the Secretary of State for Health what assessment he has made of the difficulties in communication faced by people who have had laryngectomies. [188889]
12 Oct 2004 : Column 262W
Dr. Ladyman: No assessment has been carried out centrally.
Teriparatide
Mr. Edwards: To ask the Secretary of State for Health (1) what assessment he has made of teriparatide for the treatment of osteoporosis; [189045]
(2) what guidance is given to local health trusts and local health boards about the availability of teriparatide on the NHS. [189046]
Dr. Ladyman: Teriparatide is being considered as part of the National Institute for Clinical Excellence's (NICE's) appraisal of the clinical effectiveness and cost effectiveness of technologies for the secondary prevention of osteoporotic fractures in postmenopausal women. NICE has developed guidance in consultation with a number of stakeholders. Final guidance was due to be published in October 2004, covering both England and Wales, but an appeal has been received against the final appraisal determination and guidance on this technology. NICE has arranged for the appeal panel to convene on 22 October 2004 to hear oral representations from the appellant. Full details are available on the NICE website at www.nice.org.uk.
In August 1999, the Department issued Health Service Circular 1999/176, which asks national health service bodies to continue with local arrangements for the managed introduction of new technologies where guidance from NICE is not available at the time the technology first became available. These arrangements should involve an assessment of all the available evidence. The circular applies to England only.